Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice
Yandi Tan,1,* Shiqi Yang,1,* Yao Ma,2 Jinlin Li,1 Qian Xie,1 Chaoqi Liu,1 Yun Zhao1 1Medical College of China Three Gorges University, Yichang, Hubei, People’s Republic of China; 2Department of Ultrasonography, Yichang Central People’s Hospital, Yichang, People’s Republ...
Main Authors: | Tan Y, Yang S, Ma Y, Li J, Xie Q, Liu C, Zhao Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-05-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/nanobubbles-containing-spd-1-and-ce6-mediate-combination-immunotherapy-peer-reviewed-fulltext-article-IJN |
Similar Items
-
Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma
by: Chen Y, et al.
Published: (2022-09-01) -
Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma
by: Chuah, Samuel, et al.
Published: (2022) -
PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
by: Qian Li, et al.
Published: (2022-12-01) -
Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers
by: Vanessa Acebes-Fernández, et al.
Published: (2020-06-01) -
The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
by: Matthew Man Pok Lee, et al.
Published: (2023-09-01)